Effects of Alzheimer's Disease in the Prediagnosis Period on Financial Outcomes
Technical Report,30 Sep 2016,29 Sep 2019
RAND Corporation Seattle United States
Pagination or Media Count:
The goal of this research is to understand how Alzheimers Disease ADbefore it is diagnosable using currently availability toolsaffects the financial well-being of the individuals and families of those it afflicts. We conduct analyses of the Health and Retirement Study HRS data linked to Medicare claims data. The HRS includes longitudinal information on financial outcomes for a large panel of U.S. adults over age 50. Linking the HRS to Medicare claims data enables us to identify individuals who were diagnosed with AD by a physician and their date of diagnosis, so that we can look backward over time at the vulnerable period prior to diagnosis. In Year 1 of our project, we constructed the merged data derived key dependent and independent variables and calculated descriptive statistics. In Year 2, we performed analyses of the effect of AD on financial outcomes and drafted our first paper. In Year 3, completed our analyses and disseminated our results.
- Medicine and Medical Research
- Economics and Cost Analysis